MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.xphs.2023.11.006

Медицинская библиотека · Journal of pharmaceutical sciences · 2023

Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice.

Nishimura Tomohiro, Ishii Mari, Tanaka Hiroaki, Noguchi Saki, Ikeda Tomoaki, Tomi Masatoshi

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Tadalafil, a phosphodiesterase 5 (PDE5) inhibitor, is a candidate therapeutic agent for fetal growth restriction and hypertensive disorders of pregnancy. In this study, we elucidated the fetal transfer of tadalafil in comparison with that of sildenafil, the first PDE5 inhibitor to be approved. We also examined the contributions of multidrug resistance protein 1 (MDR1) and breast cancer resistance protein (BCRP) to fetal transfer. Tadalafil or sildenafil was administered to wild-type, Mdr1a/b-double-knockout or Bcrp-knockout pregnant mice by continuous infusion from gestational day (GD) 14.5 to 17.5, and the fetal-to-maternal plasma concentration ratio of unbound drug (unbound F/M ratio) was evaluated at GD 17.5. The values of unbound F/M ratio of tadalafil and sildenafil in wild-type mice were 0.80 and 1.6, respectively. The unbound F/M ratio of tadalafil was increased to 1.1 and 1.7 in Mdr1a/b-knockout and Bcrp-knockout mice, respectively, while the corresponding values for sildenafil were equal to or less than that in wild-type mice, respectively. A transcellular transport study revealed that basal-to-apical transport of both tadalafil and sildenafil was significantly higher than transport in the opposite direction in MDCKII-BCRP cells. Our research reveals that tadalafil is a newly identified substrate of human and mouse BCRP, and it appears that the fetal transfer of tadalafil is, at least in part, attributed to the involvement of BCRP within the placental processes in mice. The transfer of sildenafil to the fetus was not significantly constrained by BCRP, even though sildenafil was indeed a substantial substrate for BCRP.

Для цитирования: Nishimura Tomohiro, Ishii Mari, Tanaka Hiroaki, Noguchi Saki, Ikeda Tomoaki, Tomi Masatoshi. Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice.. Journal of pharmaceutical sciences. 2023. DOI: 10.1016/j.xphs.2023.11.006.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.